06 Nov, 2007 from washingtonpost.com - Today's Highlights

[1]Heart Surgery Drug Sales Halted

Trasylol sales suspended while FDA reviews study showing patients on drug face higher risk of dying.

link: http://www.washingtonpost.com/wp-dyn/content/article/2007/11/05/AR2007110500222.html?nav=rss_email/components

[1] <http://www.washingtonpost.com/wp-dyn/content/article/2007/11/05/AR2007110500222.html?nav=rss_email/components>